Relationship between cardiac fibroblast activation protein activity by positron emission tomography and cardiovascular disease
Background: FAP (fibroblast activation protein) plays an important role in cardiac wound healing and remodeling. Although initially developed as a theranostic ligand for metastasized cancer, FAPI (FAP inhibitor) tracers have recently been used to study cardiac remodeling following myocardial infarct...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
11 Sep 2020
|
| In: |
Circulation. Cardiovascular imaging
Year: 2020, Jahrgang: 13, Heft: 9 |
| ISSN: | 1942-0080 |
| DOI: | 10.1161/CIRCIMAGING.120.010628 |
| Online-Zugang: | Resolving-System, Volltext: https://doi.org/10.1161/CIRCIMAGING.120.010628
|
| Verfasserangaben: | Markus B. Heckmann, MD, Finn Reinhardt, Daniel Finke, MD, Hugo A. Katus, MD, Uwe Haberkorn, Florian Leuschner, MD, and Lorenz H. Lehmann, MD |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1742059031 | ||
| 003 | DE-627 | ||
| 005 | 20220819043334.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201204s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/CIRCIMAGING.120.010628 |2 doi | |
| 035 | |a (DE-627)1742059031 | ||
| 035 | |a (DE-599)KXP1742059031 | ||
| 035 | |a (OCoLC)1341383158 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Heckmann, Markus B. |d 1986- |e VerfasserIn |0 (DE-588)1120448077 |0 (DE-627)873392434 |0 (DE-576)480359253 |4 aut | |
| 245 | 1 | 0 | |a Relationship between cardiac fibroblast activation protein activity by positron emission tomography and cardiovascular disease |c Markus B. Heckmann, MD, Finn Reinhardt, Daniel Finke, MD, Hugo A. Katus, MD, Uwe Haberkorn, Florian Leuschner, MD, and Lorenz H. Lehmann, MD |
| 264 | 1 | |c 11 Sep 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 04.12.2020 | ||
| 520 | |a Background: FAP (fibroblast activation protein) plays an important role in cardiac wound healing and remodeling. Although initially developed as a theranostic ligand for metastasized cancer, FAPI (FAP inhibitor) tracers have recently been used to study cardiac remodeling following myocardial infarction in small-animal models. The aim of the study was to evaluate the activity of FAP via FAPI-positron emission tomography-computed tomography scans in human hearts. Methods: FAPI-positron emission tomography-computed tomography scans of 229 patients of 2 consecutive cohorts (modeling cohort: n=185; confirmatory cohort: n=44) suffering from metastasized cancer were analyzed applying the American Heart Association 17-segment model of the left ventricle. Logistic regression models were created using data from the modeling cohort. Multivariate regression models were established using Akaike information criterion in a step-down approach. Results: Fourteen percent of patients had preexisting coronary artery disease (n=31), 33% arterial hypertension (n=75), and 12% diabetes mellitus type II (n=28). Forty-three percent had been treated with platin derivatives (n=100), 14% with anthracyclines (n=32), and 10% had a history of prior radiation to the chest (n=23). High left ventricular FAPI signals correlated with the presence of cardiovascular risk factors (odds ratio [OR], 4.3,P=0.0029), a focal myocardial signal pattern (OR, 3.9,P=0.0068), diabetes mellitus type II (OR, 4.1,P=0.046), and beta-blocker use (OR, 3.8,P=0.049) in univariate regression models. In a multivariate analysis, increased signal intensity was significantly higher in patients with cardiovascular risk factors (overweight [OR, 2.6,P=0.023], diabetes mellitus type II [OR, 2.9,P=0.041], certain chemotherapies [platinum derivatives; OR, 3.0,P=0.034], and a history of radiation to the chest [OR, 3.5,P=0.024]). A focal enrichment pattern was more frequently observed in patients with known cardiovascular risk factors (P<0.0001). Conclusions: FAPI-positron emission tomography-computed tomography scans represent a new imaging modality to investigate cardiac FAP. High signal intensities correlate with cardiovascular risk factors and metabolic disease. | ||
| 650 | 4 | |a alpha | |
| 650 | 4 | |a diabetes mellitus | |
| 650 | 4 | |a fibroblast | |
| 650 | 4 | |a myocardial infarction | |
| 650 | 4 | |a risk factors | |
| 650 | 4 | |a tomography | |
| 700 | 1 | |a Reinhardt, Finn |e VerfasserIn |0 (DE-588)1265527377 |0 (DE-627)1814416382 |4 aut | |
| 700 | 1 | |a Finke, Daniel |d 1988- |e VerfasserIn |0 (DE-588)1148566899 |0 (DE-627)1008764876 |0 (DE-576)496329553 |4 aut | |
| 700 | 1 | |a Katus, Hugo |d 1951- |e VerfasserIn |0 (DE-588)108916618 |0 (DE-627)577155040 |0 (DE-576)289625076 |4 aut | |
| 700 | 1 | |a Haberkorn, Uwe |d 1959- |e VerfasserIn |0 (DE-588)1022913905 |0 (DE-627)717331245 |0 (DE-576)366166352 |4 aut | |
| 700 | 1 | |a Leuschner, Florian |e VerfasserIn |0 (DE-588)1072736144 |0 (DE-627)828165742 |0 (DE-576)189305347 |4 aut | |
| 700 | 1 | |a Lehmann, Lorenz |d 1980- |e VerfasserIn |0 (DE-588)131855212 |0 (DE-627)515807184 |0 (DE-576)298796104 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Circulation. Cardiovascular imaging |d Philadelphia, Pa. : Lippincott, Williams & Wilkins, 2008 |g 13(2020), 9 |h Online-Ressource |w (DE-627)573095884 |w (DE-600)2440475-5 |w (DE-576)299311074 |x 1942-0080 |7 nnas |a Relationship between cardiac fibroblast activation protein activity by positron emission tomography and cardiovascular disease |
| 773 | 1 | 8 | |g volume:13 |g year:2020 |g number:9 |a Relationship between cardiac fibroblast activation protein activity by positron emission tomography and cardiovascular disease |
| 856 | 4 | 0 | |u https://doi.org/10.1161/CIRCIMAGING.120.010628 |x Resolving-System |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201204 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 131855212 |a Lehmann, Lorenz |m 131855212:Lehmann, Lorenz |d 910000 |d 910100 |d 50000 |e 910000PL131855212 |e 910100PL131855212 |e 50000PL131855212 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 7 |y j | ||
| 998 | |g 1072736144 |a Leuschner, Florian |m 1072736144:Leuschner, Florian |d 910000 |d 910100 |e 910000PL1072736144 |e 910100PL1072736144 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 1022913905 |a Haberkorn, Uwe |m 1022913905:Haberkorn, Uwe |d 910000 |d 911400 |e 910000PH1022913905 |e 911400PH1022913905 |k 0/910000/ |k 1/910000/911400/ |p 5 | ||
| 998 | |g 108916618 |a Katus, Hugo |m 108916618:Katus, Hugo |d 910000 |d 910100 |d 50000 |e 910000PK108916618 |e 910100PK108916618 |e 50000PK108916618 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 4 | ||
| 998 | |g 1148566899 |a Finke, Daniel |m 1148566899:Finke, Daniel |d 910000 |d 910100 |e 910000PF1148566899 |e 910100PF1148566899 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 1265527377 |a Reinhardt, Finn |m 1265527377:Reinhardt, Finn |d 50000 |e 50000PR1265527377 |k 0/50000/ |p 2 | ||
| 998 | |g 1120448077 |a Heckmann, Markus B. |m 1120448077:Heckmann, Markus B. |d 910000 |d 910100 |e 910000PH1120448077 |e 910100PH1120448077 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1742059031 |e 3817321732 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","roleDisplay":"VerfasserIn","given":"Markus B.","family":"Heckmann","display":"Heckmann, Markus B."},{"role":"aut","roleDisplay":"VerfasserIn","given":"Finn","family":"Reinhardt","display":"Reinhardt, Finn"},{"display":"Finke, Daniel","family":"Finke","given":"Daniel","role":"aut","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Hugo","family":"Katus","display":"Katus, Hugo"},{"family":"Haberkorn","display":"Haberkorn, Uwe","role":"aut","roleDisplay":"VerfasserIn","given":"Uwe"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Florian","family":"Leuschner","display":"Leuschner, Florian"},{"display":"Lehmann, Lorenz","family":"Lehmann","given":"Lorenz","roleDisplay":"VerfasserIn","role":"aut"}],"id":{"eki":["1742059031"],"doi":["10.1161/CIRCIMAGING.120.010628"]},"language":["eng"],"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"11 Sep 2020"}],"relHost":[{"note":["Gesehen am 28.11.2016"],"title":[{"title_sort":"Circulation","subtitle":"journal of the American Heart Association","title":"Circulation","partname":"Cardiovascular imaging"}],"corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"American Heart Association"}],"disp":"Relationship between cardiac fibroblast activation protein activity by positron emission tomography and cardiovascular diseaseCirculation. Cardiovascular imaging","part":{"volume":"13","text":"13(2020), 9","issue":"9","year":"2020"},"pubHistory":["1.2008 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"zdb":["2440475-5"],"issn":["1942-0080"],"eki":["573095884"]},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"origin":[{"publisherPlace":"Philadelphia, Pa.","dateIssuedDisp":"2008-","publisher":"Lippincott, Williams & Wilkins","dateIssuedKey":"2008"}],"titleAlt":[{"title":"Circulation / Cardiovascular imaging"}],"recId":"573095884"}],"recId":"1742059031","type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Markus B. Heckmann, MD, Finn Reinhardt, Daniel Finke, MD, Hugo A. Katus, MD, Uwe Haberkorn, Florian Leuschner, MD, and Lorenz H. Lehmann, MD"]},"note":["Gesehen am 04.12.2020"],"title":[{"title":"Relationship between cardiac fibroblast activation protein activity by positron emission tomography and cardiovascular disease","title_sort":"Relationship between cardiac fibroblast activation protein activity by positron emission tomography and cardiovascular disease"}]} | ||
| SRT | |a HECKMANNMARELATIONSH1120 | ||